Modus Therapeutics participates in the Biostock Life Science Summit 2021
Stockholm, Tuesday 19 October 2021. Modus Therapeutics Holding AB ("Modus") announces today that the company's CEO John Öhd will participate in Biostock's annual conference Biostock Life science summit to update on the company's key activities and expected milestones in the development work of the drug candidate sevuparin.The presentation will take place at 10:20 on 21 October. Follow this link to the presentation For more information on Modus Therapeutics, please contact: John Öhd, VD, Modus Therapeutics Telefon: +46 (0) 70 766 80